FreeIn the Archives Jänne, Ramalingam, Yu, Winn, Williams, Legg discuss today’s challenges in EGFR research at Yale SPORE workshop July 12, 2024Vol.50 No.28
JudiciaryNews Analysis Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care July 05, 2024Vol.50 No.27By Matthew Bin Han Ong
Conversation with The Cancer Letter Georgetown’s Zachary Baron on the post-Chevron era: We need guardrails about when agency expertise should be cast aside July 05, 2024Vol.50 No.27By Matthew Bin Han Ong
Guest EditorialSatire A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supplyWarning: This is not a public health recommendation. Do not implement. July 05, 2024Vol.50 No.27By Michael A. Friedman
Cancer History ProjectGuest Editorial At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago July 05, 2024Vol.50 No.27By Katerina A. Politi and Roy S. Herbst
FreeIn the Archives The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop July 05, 2024Vol.50 No.27
High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forwardNCI’s Youth Enjoy Science (YES) program also invests in student scientists June 28, 2024Vol.50 No.26By McKenzie Prillaman
NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers June 28, 2024Vol.50 No.26By Matthew Bin Han Ong
White House At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials June 28, 2024Vol.50 No.26By McKenzie Prillaman
FreeObituary Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82 June 28, 2024Vol.50 No.26By Jacquelyn Cobb
